Document Detail

Etoposide, cadmium chloride, benzo[a]pyrene, cyclophosphamide and colchicine tested in the in vitro mammalian cell micronucleus test (MNvit) in the presence and absence of cytokinesis block using L5178Y mouse lymphoma cells and 2-aminoanthracene tested in MNvit in the absence of cytokinesis block using TK6 cells at AstraZeneca UK, in support of OECD draft Test Guideline 487.
MedLine Citation:
PMID:  19761867     Owner:  NLM     Status:  In-Process    
At the laboratories of AstraZeneca, Alderley Park, UK the reference genotoxic agents etoposide (a topoisomerase II inhibitor), cadmium chloride (an inorganic carcinogen), colchicine (an aneugen that inhibits tubulin polymerisation), benzo[a]pyrene (a metabolism dependent reference genotoxin) and cyclophosphamide (a metabolism dependent reference genotoxin) were tested in the in vitro micronucleus assay (MNvit), using mouse lymphoma L5178Y cells, with and without cytokinesis block. Further, 2-aminoanthracene (a metabolism dependent weak clastogen) was tested in the MNvit, using TK6 cells, without cytokinesis block. This was done in support of the toxicity (cell death and cytostasis) measures recommended in the late 2007 version of the draft OECD Test Guideline 487 for the testing of chemicals. All six reference agents were positive in the MNvit without cytokinesis block at concentrations giving approximately 50% toxicity or less as defined by draft Test Guideline 487 recommended measures, relative population doublings and relative increase in cell counts. Furthermore, the five agents tested with cytokinesis block were positive in the MNvit at concentrations giving approximately 50% toxicity or less as assessed by replicative index. Accordingly, this work supports the premise that relative population doublings and relative increase in cell counts are appropriate measures of toxicity for the non-cytokinesis-blocked in vitro micronucleus assay.
Michael D Fellows; Michael R O'Donovan
Related Documents :
1383747 - An evaluation of the e. coli k-12 uvrb/reca dna repair host-mediated assay. i. in vitro...
21293137 - Genome-wide meta-analysis of joint tests for genetic and gene-environment interaction e...
4033157 - Different modes of cell death and related phenomena: a proposal for a meaningful termin...
6197867 - No effect of delayed cutaneous hypersensitivity testing (multitest) on blood lymphocyte...
2373087 - Disk diffusion susceptibility testing of haemophilus influenzae using haemophilus test ...
10386357 - Comparison of six respirator fit-test methods with an actual measurement of exposure in...
Publication Detail:
Type:  Journal Article     Date:  2009-09-15
Journal Detail:
Title:  Mutation research     Volume:  702     ISSN:  0027-5107     ISO Abbreviation:  Mutat. Res.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2011-01-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0400763     Medline TA:  Mutat Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  163-70     Citation Subset:  IM    
Copyright Information:
Copyright © 2009. Published by Elsevier B.V.
AstraZeneca, R&D Alderley Park, Macclesfield, Cheshire, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Immortality and the base of multicellular life: Lessons from cnidarian stem cells.
Next Document:  Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxyl...